{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:40:20Z","timestamp":1783039220103,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Australian Government Research Training Program Scholarship"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.canep.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T13:02:15Z","timestamp":1522069335000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Changes in the prevalence of comorbidity in the Australian population with cancer, 2007\u20132014"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-5253","authenticated-orcid":false,"given":"Huah Shin","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogda","family":"Koczwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6442-4409","authenticated-orcid":false,"given":"David","family":"Roder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Vitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2018.03.010_bib0005","series-title":"All Cancers in Australia","author":"Australian Government Cancer Australia","year":"2017"},{"key":"10.1016\/j.canep.2018.03.010_bib0010","series-title":"Cancer in Australia: An Overview 2014. Cancer Series No. 90. Cat. No. CAN 88","author":"Australian Institute of Health and Welfare","year":"2014"},{"issue":"10","key":"10.1016\/j.canep.2018.03.010_bib0015","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJMra1203528","article-title":"Behavioral and dietary risk factors for noncommunicable diseases","volume":"369","author":"Ezzati","year":"2013","journal-title":"NEJM"},{"issue":"5","key":"10.1016\/j.canep.2018.03.010_bib0020","first-page":"579","article-title":"The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review","volume":"16","author":"Rim","year":"2016","journal-title":"Expert Rev. Pharmcoecon. Outcome Res."},{"issue":"Suppl. 1","key":"10.1016\/j.canep.2018.03.010_bib0025","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.3747\/co.23.2995","article-title":"Cost trajectories for cancer patients","volume":"23","author":"Wodchis","year":"2016","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.canep.2018.03.010_bib0030","series-title":"Sharpening the Focus: Chronic Conditions in Cancer. Report from the Cancer and Chronic Condtions Think Tank","year":"2014"},{"key":"10.1016\/j.canep.2018.03.010_bib0035","series-title":"4364.0 \u2013 National Health Survey: Summary of Results, 2007\u20132008 (reissue) Explanatory Notes","author":"Australian Bureau of Statistics","year":"2009"},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0040","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1111\/ajco.12677","article-title":"Comorbidity, physical and mental health among cancer patients and survivors: an Australian population-based study","volume":"14","author":"Ng","year":"2018","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.canep.2018.03.010_bib0045","series-title":"National Strategic Framework for Chronic Conditions","author":"Australian Health Ministers\u2019 Advisory Council","year":"2017"},{"key":"10.1016\/j.canep.2018.03.010_bib0050","series-title":"4363.0.55.001 \u2013 Australian Health Survey: Users\u2019 Guide, 2011\u201313 Response Rates","author":"Australian Bureau of Statistics","year":"2013"},{"key":"10.1016\/j.canep.2018.03.010_bib0055","series-title":"4363.0 \u2013 National Health Survey Users\u2019 Guide, 2014\u201315 : Response Rates","author":"Australian Bureau of Statistics","year":"2017"},{"key":"10.1016\/j.canep.2018.03.010_bib0060","series-title":"Microdata Entry Page","author":"Australian Bureau of Statistics","year":"2017"},{"key":"10.1016\/j.canep.2018.03.010_bib0065","series-title":"4363.0 \u2013 National Health Survey Users\u2019 Guide, 2014\u201315 : Cancer","author":"Australian Bureau of Statistics","year":"2017"},{"key":"10.1016\/j.canep.2018.03.010_bib0070","series-title":"Australia\u2019s Health 2016. Australia\u2019s Health Series No. 15. Cat. No. AUS 199","author":"Australian Institute of Health and Welfare","year":"2016"},{"key":"10.1016\/j.canep.2018.03.010_bib0075","series-title":"Australia\u2019s Health 2014. Australia\u2019s Health Series No. 14. Cat. No. AUS 178","author":"Australian Institute of Health and Welfare","year":"2014"},{"key":"10.1016\/j.canep.2018.03.010_bib0080","series-title":"4324.0 \u2013 Information Paper: National Health Survey, Basic and Expanded CURF, 2007\u201308","author":"Australian Bureau of Statistics","year":"2010"},{"key":"10.1016\/j.canep.2018.03.010_bib0085","series-title":"4363.0.55.001 \u2013 Australian Health Survey Users\u2019 Guide 2011\u201313 Appendix 1: Sample Counts and Estimates Australian Bureau of Statistics","author":"Australian Bureau of Statistics","year":"2013"},{"key":"10.1016\/j.canep.2018.03.010_bib0090","series-title":"4363.0 \u2013 National Health Survey Users\u2019 Guide 2014-15 Appendix 1: Sample Counts and Estimates","author":"Australian Bureau of Statistics","year":"2017"},{"issue":"10","key":"10.1016\/j.canep.2018.03.010_bib0095","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/00048674.2010.490520","article-title":"Changes in the prevalence of major depression in an Australian community sample between 1998 and 2008","volume":"44","author":"Goldney","year":"2010","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0004867413495317","article-title":"Willingness to disclose a mental disorder and knowledge of disorders in others: changes in Australia over 16 years","volume":"48","author":"Reavley","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0105","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/wps.20388","article-title":"Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries","volume":"16","author":"Jorm","year":"2017","journal-title":"World Pyschiatry"},{"key":"10.1016\/j.canep.2018.03.010_bib0110","series-title":"4364.0.55.001 \u2013 National Health Survey: First Results, 2014\u201315 Data Cubes","author":"Australian Bureau of Statistics","year":"2015"},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12963-014-0031-z","article-title":"Ten-year trends in major lifestyle risk factors using an ongoing population surveillance system in Australia","volume":"12","author":"Taylor","year":"2014","journal-title":"Popul. Health Metr."},{"issue":"4","key":"10.1016\/j.canep.2018.03.010_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125233","article-title":"The use of a chronic disease and risk factor surveillance system to determine the age, period and cohort effects on the prevalence of obesity and diabetes in South Australian adults-2003\u20132013","volume":"10","author":"Taylor","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.canep.2018.03.010_bib0125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCULATIONAHA.113.002424","article-title":"Secular Trends in Cardiovascular Disease and Its Risk Factors in Japanese: Half-Century Data from the Hisayama Study (1961\u20132009)","volume":"128","author":"Hata","year":"2013","journal-title":"Circulation"},{"issue":"3\u20134","key":"10.1016\/j.canep.2018.03.010_bib0130","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1503\/cmaj.081629","article-title":"Trends in risk factors for cardiovascular disease in Canada: temporal, socio-demographic and geographic factors","volume":"181","author":"Lee","year":"2009","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0135","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/dc07-0531","article-title":"Effects of age, time period, and birth cohort on the prevalence of diabetes and obesity in Korean men","volume":"31","author":"Kwon","year":"2008","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.canep.2018.03.010_bib0140","doi-asserted-by":"crossref","first-page":"e007232","DOI":"10.1136\/bmjopen-2014-007232","article-title":"Temporal trends in cardiovascular disease risk factors among white, South Asian, Chinese and black groups in Ontario, Canada, 2001 to 2012: a population-based study","volume":"5","author":"Chiu","year":"2015","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.canep.2018.03.010_bib0145","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","article-title":"Anticipating the \u201cSilver Tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States","volume":"25","author":"Bluethmann","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.canep.2018.03.010_bib0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5694\/j.1326-5377.2006.tb00207.x","article-title":"Trends in asthma prevalence and population changes in South Australia, 1990\u20132003","volume":"184","author":"Wilson","year":"2006","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1398-9995.2009.02244.x","article-title":"Is the prevalence of asthma declining? Systematic review of epidemiological studies","volume":"65","author":"Anandan","year":"2010","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.canep.2018.03.010_bib0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5415\/apallergy.2013.3.3.145","article-title":"Allergic diseases and air pollution","volume":"3","author":"Lee","year":"2013","journal-title":"Asia Pac. Allergy"},{"issue":"4","key":"10.1016\/j.canep.2018.03.010_bib0165","doi-asserted-by":"crossref","first-page":"A70","DOI":"10.1289\/ehp.124-A70","article-title":"Pollen overload: seasonal allergies in a changing climate","volume":"124","author":"Schmidt","year":"2016","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5694\/mja13.10701","article-title":"Differences in chronic conditions and lifestyle behaviour between people with a history of cancer and matched controls","volume":"201","author":"Berry","year":"2014","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.canep.2018.03.010_bib0175","series-title":"Macmillan Cancer Support, National Cancer Intelligence Network (NCIN), Monitor Deloitte. Routes from Diagnosis: The Most Detailed Map of Cancer Survivorship Yet","year":"2014"},{"issue":"9","key":"10.1016\/j.canep.2018.03.010_bib0180","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual report to the nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0185","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejcsup.2014.03.002","article-title":"Cardiovascular disease after cancer therapy","volume":"12","author":"Aleman","year":"2014","journal-title":"EJC Suppl."},{"key":"10.1016\/j.canep.2018.03.010_bib0190","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21341","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"10","key":"10.1016\/j.canep.2018.03.010_bib0195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","article-title":"Bone loss and fracture risk associated with cancer therapy","volume":"11","author":"Guise","year":"2006","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0200","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10067-009-1310-0","article-title":"Musculoskeletal manifestations in patients with malignant disease","volume":"29","author":"Gheita","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.canep.2018.03.010_bib0205","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0210","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/EJE-13-0586","article-title":"Endocrine side effects of anti-cancer drugs: effects of anti-cancer targeted therapies on lipid and glucose metabolism","volume":"170","author":"Verg\u00e8s","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0215","first-page":"106","article-title":"Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management","volume":"25","author":"Boussios","year":"2012","journal-title":"Ann. Gastroenterol."},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bpg.2008.11.016","article-title":"Acute and long-term gastrointestinal consequences of chemotherapy","volume":"23","author":"Di Fiore","year":"2009","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0225","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature","volume":"61","author":"Bud\u00e4us","year":"2012","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11912-009-0071-x","article-title":"Neurologic complications of cancer and its treatment","volume":"12","author":"Giglio","year":"2010","journal-title":"Curr. Oncol. Rep."},{"issue":"4","key":"10.1016\/j.canep.2018.03.010_bib0235","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3892\/ol.2015.2944","article-title":"Depression in cancer patients: pathogenesis, implications and treatment (review)","volume":"9","author":"Smith","year":"2015","journal-title":"Oncol. Lett."},{"issue":"Suppl 5","key":"10.1016\/j.canep.2018.03.010_bib0240","doi-asserted-by":"crossref","first-page":"v244","DOI":"10.1093\/annonc\/mdq202","article-title":"Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO clinical practice guidelines for use","volume":"21","author":"Schrijvers","year":"2010","journal-title":"Ann. Oncol."},{"issue":"15","key":"10.1016\/j.canep.2018.03.010_bib0245","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European cancer anaemia survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.canep.2018.03.010_bib0250","article-title":"Ocular adverse effects of anti-cancer chemotherapy","volume":"1","author":"Singh","year":"2012","journal-title":"J. Cancer Ther. Res."},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4321\/S1885-642X2006000200001","article-title":"Ocular toxicity of systemic anticancer chemotherapy","volume":"4","author":"Omoti","year":"2006","journal-title":"Pharm. Pract. (Granada)"},{"issue":"7","key":"10.1016\/j.canep.2018.03.010_bib0260","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G","article-title":"Ocular toxicity and cancer chemotherapy: a review","volume":"78","author":"Al-Tweigeri","year":"1996","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.canep.2018.03.010_bib0265","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1590\/S0104-11692008000500008","article-title":"RTOG criteria to evaluate acute skin reaction and its risk factors in patients with breast cancer submitted to radiotherapy","volume":"16","author":"Pires","year":"2008","journal-title":"Rev. Lat. Am. Enfermagem"},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2296-13-60","article-title":"Excess of health care use in general practice and of comorbid chronic conditions in cancer patients compared to controls","volume":"13","author":"Jabaaij","year":"2012","journal-title":"BMC Fam. Pract."},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0275","first-page":"359","article-title":"Healthcare utilisation among cancer survivors over 50 years of age","volume":"109","author":"Coughlan","year":"2016","journal-title":"Ir. Med. J."},{"issue":"4","key":"10.1016\/j.canep.2018.03.010_bib0280","first-page":"159","article-title":"Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data","volume":"40","author":"Xiao","year":"2013","journal-title":"J. Registry Manage."},{"issue":"1","key":"10.1016\/j.canep.2018.03.010_bib0285","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1111\/ajco.12130","article-title":"Identifying important comorbidity among cancer populations using administrative data: prevalence and impact on survival","volume":"12","author":"Sarfati","year":"2016","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canep.2018.03.010_bib0290","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/0284186X.2014.1001496","article-title":"Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer","volume":"54","author":"Gottlieb","year":"2015","journal-title":"Acta Oncol."},{"issue":"7","key":"10.1016\/j.canep.2018.03.010_bib0295","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.canep.2018.03.010_bib0300","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adults patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthristis Res. Ther."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118300948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782118300948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T09:07:13Z","timestamp":1570957633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782118300948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":60,"alternative-id":["S1877782118300948"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2018.03.010","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the prevalence of comorbidity in the Australian population with cancer, 2007\u20132014","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}